https://orcid.org/0000-0002-8647-3911
Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Linlin Guo, Jay Overholser, Heather Darby, Nicholas J. Ede & Pravin T.P Kaumaya. (2022) A newly discovered PD-L1 B-cell epitope peptide vaccine (PDL1-Vaxx) exhibits potent immune responses and effective anti-tumor immunity in multiple syngeneic mice models and (synergizes) in combination with a dual HER-2 B-cell vaccine (B-Vaxx). OncoImmunology 11:1.
Read now
Read now
. (2021) Human Vaccines & Immunotherapeutics: news. Human Vaccines & Immunotherapeutics 17:1, pages 2-3.
Read now
Read now
Articles from other publishers (17)
Alex Ritter, Nischal Koirala, Andreas Wieland, Pravin T. P. Kaumaya & Darrion L. Mitchell. (2023) Therapeutic Cancer Vaccines for the Management of Recurrent and Metastatic Head and Neck Cancer. JAMA Otolaryngology–Head & Neck Surgery 149:2, pages 168.
Crossref
Crossref
Rani S. Sellers & Keith Nelson. 2023. Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology. Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology
335
396
.
Topias Karjula, Hanna Elomaa, Anne Niskakangas, Olli Mustonen, Iiris Puro, Teijo Kuopio, Maarit Ahtiainen, Jukka-Pekka Mecklin, Toni T. Seppälä, Erkki-Ville Wirta, Eero Sihvo, Juha P. Väyrynen, Fredrik Yannopoulos & Olli Helminen. (2022) CD3+ and CD8+ T-Cell-Based Immune Cell Score and PD-(L)1 Expression in Pulmonary Metastases of Microsatellite Stable Colorectal Cancer. Cancers 15:1, pages 206.
Crossref
Crossref
Saleh Alrhmoun & Sergey Sennikov. (2022) The Role of Tumor-Associated Antigen HER2/neu in Tumor Development and the Different Approaches for Using It in Treatment: Many Choices and Future Directions. Cancers 14:24, pages 6173.
Crossref
Crossref
Timothy W. Phares, Jing Huang, Vinayaka Kotraiah, Mary J. Hauser, Arban Domi, Sreenivasa Oruganti, Cecille D. Browne, Peter Buontempo, Marc Mansour, James Pannucci, Moriya Tsuji & Gabriel M. Gutierrez. (2022) Viral delivery of a peptide-based immunomodulator enhances T cell priming during vaccination. Frontiers in Pharmacology 13.
Crossref
Crossref
Nicholas J. Ede, Anthony J. Good, Joshua Tobias, Erika Garner-Spitzer, Christoph C. Zielinski & Ursula Wiedermann. (2022) Development of the B cell cancer vaccine HER-vaxx for the treatment of her-2 expressing cancers. Frontiers in Oncology 12.
Crossref
Crossref
Adilai Aisa, Shanshan Weng, Xinyu Li, Ding Zhang & Ying Yuan. (2022) Immune checkpoint inhibitors combined with HER-2 targeted therapy in HER-2 positive gastroesophageal cancer. Critical Reviews in Oncology/Hematology 180, pages 103864.
Crossref
Crossref
Joshua Tobias, Mirjana Drinić, Anna Schmid, Anastasiya Hladik, Martin L. Watzenböck, Claire Battin, Erika Garner-Spitzer, Peter Steinberger, Michael Kundi, Sylvia Knapp, Christoph C. Zielinski & Ursula Wiedermann. (2022) Combined Vaccination with B Cell Peptides Targeting Her-2/neu and Immune Checkpoints as Emerging Treatment Option in Cancer. Cancers 14:22, pages 5678.
Crossref
Crossref
Navid Sobhani, Bruna Scaggiante, Rachel Morris, Dafei Chai, Martina Catalano, Dana Rae Tardiel-Cyril, Praveen Neeli, Giandomenico Roviello, Giuseppina Mondani & Yong Li. (2022) Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials. Cancer Treatment Reviews 109, pages 102429.
Crossref
Crossref
Linlin Guo, Jay Overholser, Anthony J. Good, Nicholas J. Ede & Pravin T. P. Kaumaya. (2022) Preclinical Studies of a Novel Human PD-1 B-Cell Peptide Cancer Vaccine PD1-Vaxx From BALB/c Mice to Beagle Dogs and to Non-Human Primates (Cynomolgus Monkeys). Frontiers in Oncology 12.
Crossref
Crossref
Ian W. Hamley. (2022) Peptides for Vaccine Development. ACS Applied Bio Materials 5:3, pages 905-944.
Crossref
Crossref
Kyung-Ho Jung, Jin Hee Lee, Mina Kim, Young Seok Cho & Kyung-Han Lee. (2022)
89
Zr Immuno-PET Imaging of Tumor PD-1 Reveals That PMA Upregulates Lymphoma PD-1 through NF
κ
B and JNK Signaling
. Molecular Imaging 2022.
Crossref
Crossref
Yifei Ma, Nianqi Liu, Youlong Wang, Jiling Zeng, Ying-Ying Hu, Wu Hao, Huazheng Shi, Pengfei Zhu, Jun Lv, Wei Fan & Xinjia Wang. (2021) Immune checkpoint blocking impact and nomogram prediction of COVID-19 inactivated vaccine seroconversion in patients with cancer: a propensity-score matched analysis. Journal for ImmunoTherapy of Cancer 9:11, pages e003712.
Crossref
Crossref
Hester A. Doyle, Renelle J. Gee, Tyler D. Masters, Christian R. Gee, Carmen J. Booth, Elizabeth Peterson-Roth, Raymond A. Koski, Stuart C. Helfand, Lauren Price, Deborah Bascombe, Dorothy Jackson, Rita Ho, Gerald R. Post & Mark J. Mamula. (2021) Vaccine-induced ErbB (EGFR/HER2)-specific immunity in spontaneous canine cancer. Translational Oncology 14:11, pages 101205.
Crossref
Crossref
J. Tobias, P. Steinberger, M. Drinić & U. Wiedermann. (2021) Emerging targets for anticancer vaccination: PD-1. ESMO Open 6:5, pages 100278.
Crossref
Crossref
Linlin Guo & Pravin T. P. Kaumaya. (2021) First prototype checkpoint inhibitor B-cell epitope vaccine (PD1-Vaxx) en route to human Phase 1 clinical trial in Australia and USA: exploiting future novel synergistic vaccine combinations. British Journal of Cancer 125:2, pages 152-154.
Crossref
Crossref
Vignesh Kamath. (2021) Cancer vaccines: An unkept promise?. Drug Discovery Today 26:6, pages 1347-1352.
Crossref
Crossref